US President Joe Biden’s earlier support for a vaccine patent waiver raised hopes at the Covid-19 summit late last month. Expectations were high as Biden had supported a patent waiver, albeit only for vaccines. Hence, unless the governments of rich countries stop opposing it, forthcoming WTO meetings will not achieve much. Rich defend mRNA vaccine duopolyCovid-19 vaccine supplies and prices are controlled by a few companies. The duopoly initially sold more than 90% of their vaccines to rich countries, charging up to 24 times actual production costs.
